Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Pneumatic Tube System vs. Manual Transport for Blood Samples in ED

Official title: Pneumatic Tube System Versus Personnel Transport and the Hemolysis Index of Emergency Department Blood Samples: A Randomized, Split-Sample, Single-Blind Trial

Run by Marmara University Pendik Training and Research Hospital · NCT07755007 · Data updated 2026-11-12

This study tests whether using a pneumatic tube system versus manual transport affects how often blood samples from the emergency department show hemolysis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment166 (estimated)
SponsorMarmara University Pendik Training and Research Hospital
Academic / other
Locations1 site (Istanbul, Pendik)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedNovember 2026
Study endsJanuary 2027
Registry record updatedSeptember 23, 2026
Trial IDNCT07755007 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) presenting to the Marmara University Pendik ED who require routine venous blood draws with two yellow-cap serum separator tubes drawn from the same needle.

Probably not a fit

Patients whose samples are not affected by transport method or who do not experience pre-analytical hemolysis may see no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, single-blind trial, two sequential blood tubes drawn from the same patient are transported by different methods to the lab to compare hemolysis risk. The pneumatically transported sample and the manually carried sample are analyzed at the same time to minimize waiting-time bias. The study uses a block-randomized design to assign which tube goes by each method, and includes adults in an ED setting at Marmara University Pendik Hospital. Hemolysis, diagnostic errors, and pre-analytical variability are the focus, with careful attention to transport mechanics and sample handling. Outcomes include the hemolysis index and potential implications for test accuracy and patient care.

Why it matters

Potential benefit: If successful, the findings could guide ED transport choices to reduce hemolysis-related errors and improve test reliability.

How similar studies have gone: Prior work on transport methods and hemolysis has shown mixed results; this study uses a split-sample design to control for individual variability and may clarify the impact of PTS.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older
* Presenting to the emergency department of Marmara University Pendik Training and Research Hospital
* Venous blood draw required for routine clinical care, allowing two yellow-cap (serum separator) tubes to be drawn from the same venipuncture
* Written informed consent provided by the participant or, where the acute clinical condition of the participant prevents this, by a legal representative

Exclusion Criteria:

* Known underlying hemolytic disorder (e.g., hemolytic anemia, sickle cell disease, G6PD deficiency, autoimmune hemolytic anemia, or TTP/HUS)
* Macroscopic hemolysis visible in the sample tube immediately after phlebotomy
* Age younger than 18 years

Where it's running

  • Marmara University Pendik Training and Research Hospital
    Istanbul, Pendik, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Emir Ünal — Marmara University
  • Study coordinator: Emir Ünal, Assistant Professor
  • Email: emirunal@gmail.com
  • Phone: +905327766010

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.